Health

Experts explore opportunities to reduce costs and promote health equity.

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.

Medical bills may continue to take consumers by surprise despite the No Surprises Act.

Several U.S. Supreme Court cases from this past term have significant implications for the provision of medical care.

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.

Experts recommend regulatory policies to improve long-term care in the wake of COVID-19.

A report recommends ways CMS can address the states’ failures to meet nursing home survey requirements.

As the alternative meat industry takes off, regulation will confront a new frontier.

Scholar calls for increased protections for noncitizens within the health care system.

As fecal microbiota transplantation gains traction in the medical world, regulators may need to step in.

Scholars offer suggestions for protecting abortion rights if the Supreme Court overturns Roe v. Wade.